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Introduction
The survival of patients with systemic lupus erythematosus
has increased over the last decade, which is associated
with increased risk of morbidity. Osteoporosis remains
one of leading morbidity associated with long term survi-
vals. Multiple factors have been proposed to contribute to
osteopenia, including limited physical activity, imited
exposure to sunlight, duration of the disease activity, corti-
costeroid therapy, other immunosuppressant therapy,
inadequate dietary intake of calcium and vitamins, and
renal insufficiency. Children with Juvenile onset systemic
lupus erythematosus (JSLE) are at even greater risk of
developing osteopenia since the disease develops even
before achieving their full potential peak bone mass.
Objectives
We evaluated bone mineral density (BMD) in Omani
children with JSLE in order to detect potential predictors
of reduction in bone mass.
Methods
BMD measurements were obtained in 27 JSLE patients
and 97 healthy matched controls. The age, body mass
index (BMI), BMD scores and Vitamin D levels were com-
pared in both groups. Serial annual BMD was obtained in
all JSLE patients and the first and last BMD scores were
used for comparison. Factors that may play a role in BMD
scores in the JSLE cohort including disease duration,
disease activity, current steroid, cumulative steroid, immu-
nosuppressive medication, vitamin D supplementation
were recorded.
Results
In comparing JSLE with healthy matched controls, patients
with JSLE had lower BMI (16±2 versus 19±5 kg/m2
p value 0.007) which was associated with lower overall
BMD than normal healthy cohort (0.72±09 versus
0.84±10 gm/cm 3 p value <0.001). It was interesting to
note that the vitamin D level were higher in JSLE
patients than normal healthy controls (61±17 versus
46±16 nmol/l p value <0.001).
When comparing serial BMD measurements in JSLE
patients, the mean age at diagnosis was 6±3 years with
mean disease duration of 4±3 years. All patients with JSLE
had abnormal Z score on first BMD measurement; in
addition between the first and last BMD scores there was
a significant decline in Z scores measured -2.2±0.7 versus
-2.6±0.7 ( p value 0.038). It was interesting to note that
there was no change in overall BMD measurements during
the study, while there was a significant increase in spinal
BMD scores 0.46±0.09 versus 0.53±0.13 gm/cm3 with
p value 0.002. Despite significant improvement in disease
activity during the study, SLEDIA 16±7 versus 5±4
(p value 0.001), there was a significant decline in Z score.
Other factors that may play a role in BMD measurements
in JSLE patients, such as current and overall cumulative
steroids and other immunosuppressive medication did not
have a significant correlation with decline in BMD score
in the study
Conclusion
JSLE had lower BMI and BMD at disease onset than nor-
mal healthy cohort. Disease duration seems to play a
major role in decline in Z score in the study. Other factors
such as disease activity, vitamin D levels, current and
cumulative steroids or immunosuppressive therapy did
not seems to play a major role in decline in Z score. There
was a significant increase in overall BMD spinal score in
patients with JSLE which could be explained by effect of
calcium and vitamin D supplementation. This study is not
without limitation. A larger multi-centered study is needed
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